These pages provide visibility to Repligen news, SEC filings, financial and other information that may factor into an investment decision. We welcome your questions or comments.   

investors@repligen.com

Press Releases

Search Press Releases
  
Subscribe for Email Alerts
9/15/2017
7:30 AM ET
Press Release

Repligen Announces Analyst Day and Webcast

9/15/2017

WALTHAM, Mass., Sept. 15, 2017 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will host an institutional investor and analyst meeting on Friday, September 29...

 Continue Reading
8/30/2017
3:20 PM ET
Press Release

Repligen to Present at Baird’s 2017 Global Healthcare Conference

8/30/2017

WALTHAM, Mass., Aug. 30, 2017 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that management will pre...

 Continue Reading
8/3/2017
7:30 AM ET
Earnings Release

Repligen Reports Second Quarter 2017 Financial Results

8/3/2017

Record quarterly revenue of $32.5 millionFirst half 2017 revenue growth of 16% or 18% at constant currencyEnters agreement to acquire Spectrum, Inc., which closed August 1Prices follow-on offering whi...

 Continue Reading
7/27/2017
7:00 AM ET
Press Release

Repligen to Report Second Quarter 2017 Financial Results

7/27/2017

WALTHAM, Mass., July 27, 2017 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report second quarter of 2017 financial results on Thursday, August 3, 2017...

 Continue Reading
6/27/2017
7:05 PM ET
Press Release

Repligen Corporation Prices Public Offering of Shares of Common Stock

6/27/2017

WALTHAM, Mass., June 27, 2017 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced the pricing of an underwritten public offering of 2,807,017 shares of its common stock at a publi...

 Continue Reading
Displaying 1 to 5 (of 202 releases)